-
1
-
-
0034638746
-
Statins and the risk of dementia
-
Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA: Statins and the risk of dementia. Lancet 2000; 356: 1627-1631.
-
(2000)
Lancet
, vol.356
, pp. 1627-1631
-
-
Jick, H.1
Zornberg, G.L.2
Jick, S.S.3
Seshadri, S.4
Drachman, D.A.5
-
2
-
-
0033772113
-
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors
-
Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57: 1439-1443.
-
(2000)
Arch. Neurol.
, vol.57
, pp. 1439-1443
-
-
Wolozin, B.1
Kellman, W.2
Ruosseau, P.3
Celesia, G.G.4
Siegel, G.5
-
3
-
-
77949908687
-
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
-
Feldman HH, Doody RS, Kivipelto M, et al: Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 2010; 74: 956-964.
-
(2010)
Neurology
, vol.74
, pp. 956-964
-
-
Feldman, H.H.1
Doody, R.S.2
Kivipelto, M.3
-
4
-
-
58249089520
-
Statins are associated with a reduced risk of alzheimer disease regardless of lipophilicity the rotterdam study
-
Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM: Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2009; 80: 13-17.
-
(2009)
J. Neurol. Neurosurg. Psychiatry
, vol.80
, pp. 13-17
-
-
Haag, M.D.1
Hofman, A.2
Koudstaal, P.J.3
Stricker, B.H.4
Breteler, M.M.5
-
5
-
-
0001504829
-
Simvastatin strongly reduces levels of Alz heimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
-
Fassbender K, Simons M, Bergmann C, et al: Simvastatin strongly reduces levels of Alz heimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 5856-5861.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 5856-5861
-
-
Fassbender, K.1
Simons, M.2
Bergmann, C.3
-
6
-
-
33745246852
-
Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice
-
Burns MP, Igbavboa U, Wang L, Wood WG, Duff K: Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice. Neuromolecular Med 2006; 8: 319-328.
-
(2006)
Neuromolecular. Med.
, vol.8
, pp. 319-328
-
-
Burns, M.P.1
Igbavboa, U.2
Wang, L.3
Wood, W.G.4
Duff, K.5
-
7
-
-
34848835187
-
Statins reduce amyloid-beta production through inhibition of protein isoprenylation
-
Ostrowski SM, Wilkinson BL, Golde TE, Landreth G: Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J Biol Chem 2007; 282: 26832-26844.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 26832-26844
-
-
Ostrowski, S.M.1
Wilkinson, B.L.2
Golde, T.E.3
Landreth, G.4
-
8
-
-
46449138791
-
Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model
-
Kurinami H, Sato N, Shinohara M, et al: Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model. Int J Mol Med 2008; 21: 531-537.
-
(2008)
Int. J. Mol. Med.
, vol.21
, pp. 531-537
-
-
Kurinami, H.1
Sato, N.2
Shinohara, M.3
-
9
-
-
77954960191
-
Mevastatin accelerates loss of synaptic proteins and neurite degeneration in aging cortical neurons in a heme-independent manner
-
Kannan M, Steinert JR, Forsythe ID, Smith AG, Chernova T: Mevastatin accelerates loss of synaptic proteins and neurite degeneration in aging cortical neurons in a heme-independent manner. Neurobiol Aging 2010; 31: 1543-1553.
-
(2010)
Neurobiol. Aging
, vol.31
, pp. 1543-1553
-
-
Kannan, M.1
Steinert, J.R.2
Forsythe, I.D.3
Smith, A.G.4
Chernova, T.5
-
10
-
-
0030833055
-
Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
-
Borchelt DR, Ratovitski T, van Lare J, et al: Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997; 19: 939-945.
-
(1997)
Neuron
, vol.19
, pp. 939-945
-
-
Borchelt, D.R.1
Ratovitski, T.2
Van Lare, J.3
-
11
-
-
77954574985
-
Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance
-
Shinohara M, Sato N, Kurinami H, et al: Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance. J Biol Chem 2010; 285: 22091-22102.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 22091-22102
-
-
Shinohara, M.1
Sato, N.2
Kurinami, H.3
-
12
-
-
0011444914
-
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
-
Sturchler-Pierrat C, Abramowski D, Duke M, et al: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997; 94: 13287-13292.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 13287-13292
-
-
Sturchler-Pierrat, C.1
Abramowski, D.2
Duke, M.3
|